comparemela.com

Latest Breaking News On - Neurosense therapeutics ltd - Page 2 : comparemela.com

Comparing NeuroSense Therapeutics (NASDAQ:NRSN) and Phathom Pharmaceuticals (NASDAQ:PHAT)

Comparing NeuroSense Therapeutics (NASDAQ:NRSN) and Phathom Pharmaceuticals (NASDAQ:PHAT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer s Disease

CAMBRIDGE, Mass., April 22, 2024 /PRNewswire/  NeuroSense Therapeutics Ltd. , a company developing novel treatments for severe neurodegenerative diseases announced today a collaboration in.

Neurosense Therapeutics (NRSN) Reports Positive Data Validating Phase 2b Topline Readout

Neurosense Therapeutics (NRSN) Reports Positive Data Validating Phase 2b Topline Readout
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

NeuroSense Therapeutics Ltd (NASDAQ:NRSNW) Short Interest Down 57 1% in March

NeuroSense Therapeutics Ltd. (NASDAQ:NRSNW – Get Free Report) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 1,800 shares, a decline of 57.1% from the March 15th total of 4,200 shares. Based on an average daily volume of 10,000 shares, the short-interest ratio […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.